Bright Minds Biosciences Inc. · CSE:DRUG
Perceptive Advisors LLC reported a 6.30% stake in Bright Minds Biosciences Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 15, 2025
Perceptive Advisors LLC reported a 6.30% stake in Bright Minds Biosciences Inc., 444,649 shares, as a passive investor on Mar 31, 2025. Filed May 15, 2025 (Schedule 13G/A).
- Stake
- 6.30%
- Shares
- 444,649
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Perceptive Advisors LLC | 6.30% | 444,649 |
| Joseph Edelman | 6.30% | 444,649 |
| Perceptive Life Sciences Master Fund, Ltd. | 6.30% | 444,649 |
Source
Related
- Bright Minds Biosciences Inc.
- Perceptive Advisors LLC
- Bright Minds Biosciences Inc. shareholders
- Schedule 13G/A · Perceptive Advisors LLC · Feb 17, 2026
- Schedule 13G/A · Cormorant Asset Management, LP · Aug 14, 2026
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13D/A · Ian McDonald · Jul 2, 2026
- Schedule 13G · Vestal Point Capital, LP · May 15, 2026
- Schedule 13G/A · Janus Henderson Group PLC · May 15, 2026